Diabetes Drugs Market, By Diabetes Type (Type 1 and Type 2), By Drug Class (Insulin, DPP-4 Inhibitors, GLP-1 Receptor Agonists, SGLT2 Inhibitors, and Others), By Distribution Channel (Online pharmacies, Hospital Pharmacies, and Retail Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Trends, Analysis, and Forecast till 2029

Diabetes, or diabetes mellitus, refers to a metabolic disorder in which an individual experiences high levels of blood glucose. It is usually caused by inadequate insulin production or a faulty response to insulin in the body. This disorder can lead to chronic health problems, such as cardiovascular diseases (CVDs) and renal, nerve and neural damage. Various anti-diabetic medicines, along with self-monitoring, continuous glucose monitoring and insulin delivery devices, are used for diagnosing the disorder and monitoring its effects in the body. Apart from this, numerous software- and web-based diabetes and blood glucose tracking applications and data management platforms are also being widely used across the healthcare sector. The global diabetes drugs market accounted for US$ 51.4 billion in 2019 and is estimated to be US$ 93.6 billion by 2029 and is anticipated to register a CAGR of 6.20%.

Impact of Covid-19 pandemic on market

With the outbreak of the COVID-19, various businesses are at the forefront to combat this pandemic. The pandemic has hindered the industrial supply chain and also disrupted the product segment. Government across the countries has imposed strict lockdown to limit the spread of disease. Due to this pandemic the diabetes drug market have a negative impact. According to a recent study from the Manchester University showed that the number of deaths from type 2 diabetes (T2D) in England more than doubled at the peak of the COVID-19 pandemic in April. The number of T2D diagnosed cases fell by 70% in the same period. This report will quantify the impact of a pandemic on the diabetes drugs market.

Rising prevalence of diabetes

The global diabetes drug market is majorly driven by increasing number of diabetic population. According to research, smoking increases the possibility of diabetes; more than 60% of the global population smokes, this has increased the risk of diabetes and contributed to the growth of the diabetes drug market. During last decade there is a tremendous increase in the number of diabetic population. According to International Diabetes Federation, in 2016, it was estimated that 420 million adult populations were suffering from diabetes which is increasing at the rate of 8.4% and is expected to reach 625 million by 2040.

Increasing government’s initiatives

The government is taking steps to control diabetes also increases the growth of the diabetes drugs market. For instance, WHO estimated that 422 million people globally suffered from diabetes and also indicated that 1.5 million people died from diabetes, which are some of the major factors responsible for the market growth. However, cost issues, strict regulatory rules and long approval time for drugs might be hampering the growth of the diabetes drugs market.

The global diabetes drugs market is segmented based on diabetes type, drug class, distribution channel, and region.

On the basis of diabetes type, the global diabetes drugs market is segmented into type 1 and type 2. Based on drug class, the target market is segmented into insulin, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, and others. Based on distribution channel, the target market is segmented into online pharmacies, hospital pharmacies, and retail pharmacies.

Regional Insights:

On region the global diabetes drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the most important market share in 2018 and is anticipated to dominate the market during the forecast period. Growing investments in research and development activities via many government institutions and an increase within the widespread presence of diabetes are a couple of the factors expected to account for the good-sized diabetes drugs market share in North America. Additionally, increasing knowledge about the novel anti-diabetic drugs, the introduction of anti-diabetic drugs, and beneficial reimbursement plans are probable to bolster the diabetic drugs market in North America.

Report Scope:

Attribute	Details
Base year for estimation	2020
Forecast period	2020 – 2029
Market representation	Revenue in USD Million & CAGR from 2020 – 2029
Market Segmentation	By Diabetes Type: Type 1 and Type 2 By Drug Class: Insulin, DPP-4 Inhibitors, GLP-1 Receptor Agonists, SGLT2 Inhibitors, and Others By Distribution Channel: Online pharmacies, Hospital Pharmacies, and Retail Pharmacies
Delivery Mode Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
sReport coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the global diabetes drugs market report based on diabetes type, drug class, distribution Channel, and region.

Global Diabetes Drugs Market, By Diabetes Type:

• Type 1
• Type 2

Global Diabetes Drugs Market, By Drug Class:

• Insulin
• DPP-4 Inhibitors
• GLP-1 Receptor Agonists
• SGLT2 Inhibitors
• Others

Global Diabetes Drugs Market, By Distribution Channel:

• Online pharmacies
• Hospital Pharmacies
• Retail Pharmacies

Global Diabetes Drugs Market, By Region:

• • • North America
      • • U.S.
        • Canada
    • Europe
      • • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

The key players operating in the global diabetes drugs market includes Eli Lilly, Novo Nordisk, Abbott, AstraZeneca, Biocon, Sunpharma, Sanofi, Novartis, Merck & Co., Pfizer, Daiichi Sankyo, Boehringer Ingelheim, Akros Pharma, Amgen, Adocia, Peptron, and Takeda. The market is especially characterized by collaborations and partnerships between the businesses and acquisitions of smaller players as a part of strategic expansion as well as launching their new product specimen. For instance, In April 2019, Glenmark Pharmaceuticals announced that it plans to bring its Remogliflozin Etabonate to India. The high demand for diabetes drugs in India has influenced Glenmark’s latest move. Additionally, a huge diabetic patient pool has also contributed to the high demand for diabetes drugs in India.

• Eli Lilly
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Novo Nordisk
• Abbott
• AstraZeneca
• Biocon
• Sunpharma
• Sanofi
• Novartis
• Merck & Co.
• Pfizer

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
3. Market Purview
   • Executive Summary
   • Key Findings—Global Outlook for Diabetes Drugs Strategies
     • Key Questions this Study will Answer
     • Market Snippet, By Diabetes Type
     • Market Snippet, By Drug Class
     • Market Snippet, By Distribution Channel
     • Market Snippet, By Region
   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Global Diabetes Drugs Market, By Diabetes Type, 2019 – 2029, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
     • Y-o-Y Growth Analysis (%), 2019 – 2029
     • Segment Trends
   • Type 1
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
   • Type 2
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
6. Global Diabetes Drugs Market, By Drug Class, 2019 – 2029, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
     • Y-o-Y Growth Analysis (%), 2019 – 2029
     • Segment Trends
   • Insulin
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
   • DPP-4 Inhibitors
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
   • GLP-1 Receptor Agonists
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
   • SGLT2 Inhibitors
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
7. Global Diabetes Drugs Market, By Distribution Channel, 2019 – 2029, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
     • Y-o-Y Growth Analysis (%), 2019 – 2029
     • Segment Trends
   • Online pharmacies
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
   • Hospital Pharmacies
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
   • Retail Pharmacies
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
8. Global Diabetes Drugs Market, By Region, 2019 – 2029, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
     • Y-o-Y Growth Analysis (%), 2019 – 2029
     • Regional Trends
   • North America
     • Market Size and Forecast (US$ Mn), By Diabetes Type, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Drug Class, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Distribution Channel, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
       • U.S.
       • Canada
   • Europe
     • Market Size and Forecast (US$ Mn), By Diabetes Type, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Drug Class, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Distribution Channel, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
       • Germany
       • UK
       • France
       • Russia
       • Italy
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast (US$ Mn), By Diabetes Type, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Drug Class, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Distribution Channel, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
       • China
       • India
       • Japan
       • South Korea
       • Rest of Asia Pacific
   • Latin America
     • Market Size and Forecast (US$ Mn), By Diabetes Type, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Drug Class, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Distribution Channel, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
       • Brazil
       • Mexico
       • Rest of Latin America
   • Middle East & Africa
     • Market Size and Forecast (US$ Mn), By Diabetes Type, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Drug Class, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Distribution Channel, 2019 – 2029
     • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
       • GCC
       • Israel
       • South Africa
       • Rest of Middle East
9. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
10. Company Profiles
    • • Eli Lilly
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Business Strategies
      • Novo Nordisk
      • Abbott
      • AstraZeneca
      • Biocon
      • Sunpharma
      • Sanofi
      • Novartis
      • Merck & Co.
      • Pfizer
11. The Last Word
    • Future Impact
    • About Us
    • Contact

List of Tables

TABLE List of data sources

TABLE Market drivers; Impact Analysis

TABLE Market restraints; Impact Analysis

TABLE Diabetes Drugs Market: Diabetes Type Snapshot (2019)

TABLE Segment Dashboard; Definition and Scope, by Diabetes Type

TABLE Global Diabetes Drugs Market, by Diabetes Type 2019-2029 (USD Million)

TABLE Diabetes Drugs Market: Drug Class Snapshot (2019)

TABLE Segment Dashboard; Definition and Scope, by Drug Class

TABLE Global Diabetes Drugs Market, by Drug Class 2019-2029 (USD Million)

TABLE Diabetes Drugs Market: Distribution Channel Snapshot (2019)

TABLE Segment Dashboard; Definition and Scope, by Distribution Channel

TABLE Global Diabetes Drugs Market, by Distribution Channel 2019-2029 (USD Million)

TABLE Diabetes Drugs Market: Regional snapshot (2019)

TABLE Segment Dashboard; Definition and Scope, by Region

TABLE Global Diabetes Drugs Market, by Region 2019-2029 (USD Million)

TABLE North America Diabetes Drugs Market, by Country, 2019-2029 (USD Million)

TABLE North America Diabetes Drugs Market, by Diabetes Type, 2019-2029 (USD Million)

TABLE North America Diabetes Drugs Market, by Drug Class, 2019-2029 (USD Million)

TABLE North America Diabetes Drugs Market, by Distribution Channel, 2019-2029 (USD Million)

TABLE Europe Diabetes Drugs Market, by Country, 2019-2029 (USD Million)

TABLE Europe Diabetes Drugs Market, by Diabetes Type, 2019-2029 (USD Million)

TABLE Europe Diabetes Drugs Market, by Drug Class, 2019-2029 (USD Million)

TABLE Europe Diabetes Drugs Market, by Distribution Channel, 2019-2029 (USD Million)

TABLE Asia Pacific Diabetes Drugs Market, by Country, 2019-2029 (USD Million)

TABLE Asia Pacific Diabetes Drugs Market, by Diabetes Type, 2019-2029 (USD Million)

TABLE Asia Pacific Diabetes Drugs Market, by Drug Class, 2019-2029 (USD Million)

TABLE Asia Pacific Diabetes Drugs Market, by Distribution Channel, 2019-2029 (USD Million)

TABLE Latin America Diabetes Drugs Market, by Country, 2019-2029 (USD Million)

TABLE Latin America Diabetes Drugs Market, by Diabetes Type, 2019-2029 (USD Million)

TABLE Latin America Diabetes Drugs Market, by Drug Class, 2019-2029 (USD Million)

TABLE Latin America Diabetes Drugs Market, by Distribution Channel, 2019-2029 (USD Million)

TABLE Middle East and Africa Diabetes Drugs Market, by Country, 2019-2029 (USD Million)

TABLE Middle East and Africa Diabetes Drugs Market, by Diabetes Type, 2019-2029 (USD Million)

TABLE Middle East and Africa Diabetes Drugs Market, by Drug Class, 2019-2029 (USD Million)

TABLE Middle East and Africa Diabetes Drugs Market, by Distribution Channel, 2019-2029 (USD Million)

List of Figures

FIGURE Diabetes Drugs Market segmentation

FIGURE Market research methodology

FIGURE Value chain analysis

FIGURE Porter’s Five Forces Analysis

FIGURE Market Attractiveness Analysis

FIGURE COVID-19 Impact Analysis

FIGURE Pre & Post COVID-19 Impact Comparison Study

FIGURE Competitive Landscape; Key company market share analysis, 2019

FIGURE Diabetes Type segment market share analysis, 2019 & 2029

FIGURE Diabetes Type segment market size forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Drug Class segment market share analysis, 2019 & 2029

FIGURE Drug Class segment market size forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Distribution Channel segment market share analysis, 2019 & 2029

FIGURE Distribution Channel segment market size forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Regional segment market share analysis, 2019 & 2029

FIGURE Regional segment market size forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE North America Diabetes Drugs Market share and leading players, 2019

FIGURE Europe Diabetes Drugs Market share and leading players, 2019

FIGURE Asia Pacific Diabetes Drugs Market share and leading players, 2019

FIGURE Latin America Diabetes Drugs Market share and leading players, 2019

FIGURE Middle East and Africa Diabetes Drugs Market share and leading players, 2019

FIGURE North America market share analysis by country, 2019

FIGURE U.S. Diabetes Drugs Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Canada Diabetes Drugs Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Europe Diabetes Drugs Market share analysis by country, 2019

FIGURE Germany Diabetes Drugs Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Spain Diabetes Drugs Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Italy Diabetes Drugs Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE UK Diabetes Drugs Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE France Diabetes Drugs Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Rest of the Europe Diabetes Drugs Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Asia Pacific Diabetes Drugs Market share analysis by country, 2019

FIGURE India Diabetes Drugs Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE China Diabetes Drugs Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Japan Diabetes Drugs Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE South Korea Diabetes Drugs Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Rest of APAC Diabetes Drugs Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Latin America Diabetes Drugs Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Latin America Diabetes Drugs Market share analysis by country, 2019

FIGURE Brazil Diabetes Drugs Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Mexico Diabetes Drugs Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Argentina Diabetes Drugs Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Rest of LATAM Diabetes Drugs Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Middle East and Africa Diabetes Drugs Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Middle East and Africa Diabetes Drugs Market share analysis by country, 2019

FIGURE Saudi Arabia Diabetes Drugs Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE United Arab Emirates Diabetes Drugs Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Rest of Middle East & Africa Diabetes Drugs Market size, forecast and trend analysis, 2019 to 2029 (USD Million)